Skip to main content

Currently Skimming:

Appendix D-6: The Prospects for Immunizing Against Japanese Encephalitis Virus
Pages 223-240

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 223...
... detection of Japanese encephalitis virus (JEV) IgM antibodies in cerebrospinal fluid (CSF)
From page 224...
... Louis encephalitis virus in the Americas, West Nile encephalitis virus in Southwest Asia and Africa, and Murray Valley encephalitis virus in AustraliaJ. Preliminary analysis of the nucleotide sequence of JEV (Fournier, personal communication, 1986)
From page 225...
... When brain tissues from fatal cases are examined by immunohistochemical techniques, the earliest detectable host response is extravascular migration of mononuclear phagocytes (Johnson et al., 1985~. These cells, accompanied by T-lymphocytes, cluster around infected (antigen-bearing)
From page 226...
... Rates have remained low in Japan, but in 1982 the southwestern provinces of Korea were struck by the first major epidemic there in 12 years, involving almost 3,000 children (attack rates 5 to 10 per 100,000 in affected provinces)
From page 227...
... Potential target areas include Japan, China, Thailand, Korea, Vietnam, Kampuchea, Laos, Malaysia, Indonesia, the Philippines, Nepal, northern India, and Sri Lanka. To simplify the calculations, the potential target population is considered to be the entire birth cohort of all countries in affected regions (see Table D-6.41.
From page 228...
... Laos - Assumes rates similar to northern Thailand. Malaysia - Lam, personal communication, 1985; Okuno, 1978.
From page 230...
... 230 o .,, 4~ ~ '0 0 ~ · a to Us PA lo AD U' sol PA a' l UP 00 sol PA U
From page 231...
... * Vaccine preventable illness is defined as that portion of the disease burden that could be prevented by immunization of the entire target population (at the anticipated age of administration)
From page 232...
... The principal vector species of JE are common rice-field-breeding mosquitoes present in huge numbers throughout Asia; no practical vector control measures are available or are likely to be available in the near future. Because these species feed largely at night, window screens and mosquito nets probably are useful devices for limiting, but not eliminating, exposure.
From page 233...
... A bivalent vaccine, consisting of equal parts of the Nakayama strain and the Beijing strain, was shown to induce satisfactory levels of neutralizing antibodies to all known JEV strains (Fukai, 1983~. This bivalent Biken inactivated mouse brain vaccine is currently undergoing controlled field testing in northern Thailand.
From page 234...
... The 2-8 vaccine strain was developed from the 12-1-7 strain by ultraviolet irradiation and passage in adult mice. The resultant live vaccine was shown to have a protective eff icacy of 87 percent in a trial involving 500,000 horses, but only 50 percent of 8,000 children inoculated with this vaccine developed neutralizing antibody.
From page 235...
... As noted in previous sections, several different types of reportedly efficacious JE vaccines have been developed and administered to large numbers of humans; feasibility of vaccine construction is not an issue. However, none of the existing vaccines is ideal; significant problems still exist regarding vaccine safety, cost, and the requirement for booster immunizations.
From page 236...
... 1985a. Kinetics of Japanese encephalitis virus immunoglobulin M and G antibodies in human serum and cerebrospinal fluid.
From page 237...
... 1977. Intranasal infection of monkeys with Japanese encephalitis virus: Clinical response and treatment with a nuclease-resistant derivative of poly (I)
From page 238...
... I Comparison of viremia following peripheral inoculation of Langat and Japanese encephalitis viruses.
From page 239...
... 1979. Japanese encephalitis virus in mosquito salivary glands.
From page 240...
... Pp. 198-204 in Viral Diseases in South-East Asia and the Western Pacific, J.S.


This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More information on Chapter Skim is available.